- A patient who started taking atorvastatin two weeks ago calls the pharmacy and complains of significant muscle pain and weakness. Which action should the pharmacy technician take?
Answer: Immediately refer the patient to the pharmacist for counseling on a potential adverse drug event.
Severe muscle pain (myopathy) can be a serious adverse effect of statin medications like atorvastatin, potentially leading to rhabdomyolysis. A pharmacy technician is not qualified to assess or manage adverse drug events. The patient must be immediately referred to the pharmacist, who can properly assess the situation, counsel the patient, and contact the prescriber if necessary.
- A prescription arrives for nitrofurantoin 100 mg twice daily for 5 days for a urinary tract infection. While entering the order, the technician sees the patient is 82 years old and has a documented reduced kidney function note from a recent hospital discharge summary in the profile. The patient's medication list includes furosemide, losartan, and calcium/vitamin D. The patient calls and reports nausea and shortness of breath after the first dose taken last night, and wonders if they should keep taking it. The technician knows some antibiotics may not work well or may cause more side effects in patients with poor kidney function, and that new shortness of breath can be concerning. Pharmacy policy requires pharmacist review for possible adverse drug events and appropriateness concerns in older adults with kidney impairment. The technician must decide what should be escalated to the pharmacist immediately.
Answer: Refer to the pharmacist due to kidney function concerns and new shortness of breath
This question tests the ability to identify situations requiring pharmacist intervention, focusing on patient safety and quality assurance in pharmacy settings. Pharmacist intervention is crucial when potential drug interactions, therapeutic duplications, or ADEs are identified, ensuring patient safety and optimal therapeutic outcomes. In the specific scenario, the nitrofurantoin prescription in an elderly patient with kidney impairment and new symptoms highlights the need for a pharmacist's expertise to prevent harm. The correct answer addresses the specific situation requiring pharmacist oversight for appropriateness and adverse effects, demonstrating comprehension of the intervention criteria. A common distractor might minimize symptoms as unrelated, reflecting a misunderstanding of pharmacy protocols. To help students, emphasize the importance of understanding common triggers for pharmacist review and practice identifying these in varied scenarios. Encourage familiarity with drug interaction resources and therapeutic guidelines.
- A prescription is received for levothyroxine 200 mcg daily for a patient who previously filled levothyroxine 75 mcg daily at the same pharmacy. The technician checks the profile and sees the last 75 mcg fill was 10 days ago with 80 tablets remaining, suggesting the patient is not due. The patient says, "My doctor said my thyroid is still low," but also reports feeling shaky and having trouble sleeping lately. The technician notices the new prescription has no titration note and the dose increase seems large compared to the previous strength. The patient's history includes atrial fibrillation and use of metoprolol. The pharmacy's quality assurance rules require pharmacist review for significant dose changes, early refills that may indicate confusion, and symptoms that could suggest over-treatment. The technician must decide what should prompt pharmacist oversight before dispensing the new dose.
Answer: Refer to the pharmacist to assess the large dose increase, early refill pattern, and symptoms
This question tests the ability to identify situations requiring pharmacist intervention, focusing on patient safety and quality assurance in pharmacy settings. Pharmacist intervention is crucial when potential drug interactions, therapeutic duplications, or ADEs are identified, ensuring patient safety and optimal therapeutic outcomes. In the specific scenario, the large levothyroxine dose increase with early refill and symptoms highlights the need for a pharmacist's expertise to prevent harm. The correct answer addresses the specific situation requiring pharmacist oversight for dose changes and over-treatment risks, demonstrating comprehension of the intervention criteria. A common distractor might dispense without reviewing symptoms, reflecting a misunderstanding of pharmacy protocols. To help students, emphasize the importance of understanding common triggers for pharmacist review and practice identifying these in varied scenarios. Encourage familiarity with drug interaction resources and therapeutic guidelines.
- A pregnant patient asks the pharmacy technician at the counter for advice on which over-the-counter laxative is safe to use. How should the technician respond?
Answer: Inform her that a pharmacist must assist with this type of question.
Recommending any medication, including OTC products, for a pregnant patient requires clinical knowledge to ensure the safety of both the patient and the fetus. This is a special patient population that requires pharmacist consultation. The technician should never provide medical advice or product recommendations.
- A patient asks the pharmacy technician if it is okay to switch from their prescribed Prilosec (omeprazole) to the over-the-counter version to save money. How should the technician respond?
Answer: Explain that this is a question for the pharmacist to answer.
Even though OTC Prilosec contains the same active ingredient, the pharmacist needs to be involved. The pharmacist will ensure the patient understands the correct OTC dosing, confirm the indication is appropriate for self-treatment, and check for any potential interactions or contraindications. This is a therapeutic decision that falls outside the technician's scope of practice.
- A patient mentions to the pharmacy technician that they only take their blood pressure medication on days they "feel stressed" instead of daily as prescribed. This is an example of a(n):
Answer: medication adherence issue.
The patient is not taking their medication as directed by the prescriber, which is a medication adherence issue. This can lead to uncontrolled hypertension and other health complications. The technician should recognize this and ensure the pharmacist is made aware so they can counsel the patient on the importance of proper adherence.
- A caregiver brings a prescription for a child for acetaminophen-codeine liquid for a cough. The technician reviews the patient record and sees the child is 7 years old with a history of sleep-disordered breathing and prior tonsil surgery. The caregiver says the child is "very sleepy" after the first dose given from an old bottle at home and asks if they should continue. The technician knows some opioid-containing cough products are not appropriate for children and that excessive sleepiness can be a warning sign. The caregiver is in a hurry and wants the prescription filled quickly. Pharmacy policy requires pharmacist review for pediatric opioid use, possible adverse events, and any report of excessive sedation. The technician must determine the best action to ensure safe care and appropriate counseling.
Answer: Refer to the pharmacist immediately due to pediatric safety concerns and excessive sleepiness
This question tests the ability to identify situations requiring pharmacist intervention, focusing on patient safety and quality assurance in pharmacy settings. Pharmacist intervention is crucial when potential drug interactions, therapeutic duplications, or ADEs are identified, ensuring patient safety and optimal therapeutic outcomes. In the specific scenario, the pediatric codeine prescription with sleep issues and sedation highlights the need for a pharmacist's expertise to prevent harm. The correct answer addresses the specific situation requiring pharmacist oversight for opioid safety in children, demonstrating comprehension of the intervention criteria. A common distractor might dispense without reviewing history, reflecting a misunderstanding of pharmacy protocols. To help students, emphasize the importance of understanding common triggers for pharmacist review and practice identifying these in varied scenarios. Encourage familiarity with drug interaction resources and therapeutic guidelines.
- A patient drops off a new prescription for lisinopril 20 mg daily. The technician reviews the profile: lisinopril 10 mg daily was filled last week, plus hydrochlorothiazide 25 mg daily, metformin 1000 mg twice daily, and ibuprofen 600 mg three times daily as needed for back pain. The patient history shows chronic kidney disease stage 3 and a prior note of elevated potassium. The patient says, "My doctor increased my blood pressure pill because my numbers were high," and asks if they should take both lisinopril bottles until the old one runs out. The technician notices the directions on the new prescription do not say "replace prior dose," and the patient has refills remaining on the 10 mg strength. The technician also recalls that frequent NSAID use with an ACE inhibitor and diuretic can increase kidney risk, especially in someone with kidney disease. The patient reports mild dizziness since starting the diuretic but denies swelling, rash, or trouble breathing. The pharmacy's quality checks require pharmacist review for dose changes, therapeutic duplication, and high-risk combinations. The technician must decide what should be escalated to the pharmacist immediately to prevent harm and ensure the prescriber's intent is followed.
Answer: Ask the pharmacist to review possible duplicate ACE inhibitor dosing and kidney-risk combination
This question tests the ability to identify situations requiring pharmacist intervention, focusing on patient safety and quality assurance in pharmacy settings. Pharmacist intervention is crucial when potential drug interactions, therapeutic duplications, or ADEs are identified, ensuring patient safety and optimal therapeutic outcomes. In the specific scenario, the potential duplication of lisinopril doses and the high-risk combination of an ACE inhibitor, diuretic, and NSAID in a patient with chronic kidney disease highlight the need for a pharmacist's expertise to prevent harm. The correct answer addresses the specific situation requiring pharmacist oversight for dose changes and kidney risk, demonstrating comprehension of the intervention criteria. A common distractor might misinterpret the patient's explanation as sufficient without review, reflecting a misunderstanding of pharmacy protocols. To help students, emphasize the importance of understanding common triggers for pharmacist review and practice identifying these in varied scenarios. Encourage familiarity with drug interaction resources and therapeutic guidelines.
- While processing a refill for an albuterol inhaler, the technician sees in the patient's history that it is being refilled every 10-14 days, even though it should last 30 days. This pattern suggests a need for pharmacist intervention to address:
Answer: potential overuse of a rescue inhaler, indicating poor asthma control.
Frequent refills of a rescue inhaler like albuterol are a clinical indicator that the patient's underlying condition (e.g., asthma, COPD) may be poorly controlled. This requires a pharmacist's intervention to counsel the patient on proper inhaler technique and to potentially contact the prescriber to discuss stepping up the patient's maintenance therapy.
- A patient presents a handwritten prescription for alprazolam. The technician notices the quantity, "#30 (thirty)", appears to have been altered to "#80 (eighty)". What is the most appropriate initial action?
Answer: Discreetly show the prescription to the pharmacist for evaluation.
Any suspicion of prescription alteration or forgery, especially for a controlled substance, must be handled by the pharmacist. The technician should not confront the patient or make a unilateral decision. The pharmacist needs to evaluate the prescription, verify its legitimacy with the prescriber's office, and follow all legal and professional guidelines.
- A patient calls and says they missed a dose of their warfarin and asks the technician what they should do. What is the correct action for the technician?
Answer: Refer the patient's question to the on-duty pharmacist.
Warfarin is a high-alert medication with a narrow therapeutic index. Advice about missed doses can be complex and depends on the patient's specific situation, INR levels, and prescriber's protocol. Providing this type of clinical advice is outside the scope of practice for a pharmacy technician and must be handled by a pharmacist.
- A patient with a new prescription for warfarin tells the technician they are also taking St. John's Wort, an herbal supplement, for depression. Why is this a concern that requires pharmacist intervention?
Answer: St. John's Wort can decrease the effectiveness of warfarin, increasing the risk of blood clots.
This is a classic drug-dietary supplement interaction. St. John's Wort is a CYP450 enzyme inducer, which can increase the metabolism of warfarin. This lowers the level of warfarin in the blood, reducing its anticoagulant effect and putting the patient at a higher risk for stroke or other thrombotic events. The pharmacist must be alerted to counsel the patient and contact the prescriber.
- A customer asks for an OTC sleep aid because they "can't shut off their brain at night." The technician learns the customer takes oxycodone/acetaminophen for a recent injury, drinks alcohol most evenings, and uses diphenhydramine occasionally for allergies. The customer wants to buy an OTC product containing doxylamine and says they plan to take it with their pain medication so they can "sleep through the night." The customer appears drowsy at the counter and asks if it is safe to drive in the morning. The technician knows combining sedating medicines and alcohol can increase risk of excessive sleepiness and breathing problems, and that this requires pharmacist counseling. Pharmacy policy requires pharmacist consultation when an OTC request may worsen sedation or interact with controlled medications. The technician must decide how to proceed to protect patient safety and ensure appropriate guidance.
Answer: Refer the customer to the pharmacist due to additive sedation risk with opioids and alcohol
This question tests the ability to identify situations requiring pharmacist intervention, focusing on patient safety and quality assurance in pharmacy settings. Pharmacist intervention is crucial when potential drug interactions, therapeutic duplications, or ADEs are identified, ensuring patient safety and optimal therapeutic outcomes. In the specific scenario, the OTC sleep aid request with opioid and alcohol use highlights the need for a pharmacist's expertise to prevent harm. The correct answer addresses the specific situation requiring pharmacist oversight for sedation risks, demonstrating comprehension of the intervention criteria. A common distractor might enhance effects without review, reflecting a misunderstanding of pharmacy protocols. To help students, emphasize the importance of understanding common triggers for pharmacist review and practice identifying these in varied scenarios. Encourage familiarity with drug interaction resources and therapeutic guidelines.
- A new prescription for methotrexate 2.5 mg tablets is received with directions: "Take 6 tablets by mouth daily." The technician notices the patient's profile shows rheumatoid arthritis and folic acid daily, and that methotrexate is often taken on a weekly schedule for this condition. The patient is waiting and says, "My doctor said it's a strong medicine, so I want to be careful." The technician also sees the patient takes ibuprofen as needed and has a history of mild liver disease. The technician recognizes that a daily dosing direction may be an error and could cause serious harm. Pharmacy policy requires pharmacist review for unusual dosing, high-alert medications, and potential prescribing errors. The technician must decide the best course of action before the prescription is filled or dispensed.
Answer: Refer to the pharmacist immediately to verify dosing directions and clarify with the prescriber
This question tests the ability to identify situations requiring pharmacist intervention, focusing on patient safety and quality assurance in pharmacy settings. Pharmacist intervention is crucial when potential drug interactions, therapeutic duplications, or ADEs are identified, ensuring patient safety and optimal therapeutic outcomes. In the specific scenario, the unusual daily dosing for methotrexate highlights the need for a pharmacist's expertise to prevent harm. The correct answer addresses the specific situation requiring pharmacist oversight for dosing errors, demonstrating comprehension of the intervention criteria. A common distractor might alter directions independently, reflecting a misunderstanding of pharmacy protocols. To help students, emphasize the importance of understanding common triggers for pharmacist review and practice identifying these in varied scenarios. Encourage familiarity with drug interaction resources and therapeutic guidelines.
- A patient brings in a prescription for prednisone 40 mg daily for 5 days for an asthma flare. The technician sees the patient has type 2 diabetes treated with insulin glargine nightly and insulin lispro with meals. The patient says, "Steroids always make my sugar go crazy," and asks if they should cut their insulin in half to avoid weight gain. The patient also reports increased thirst and frequent urination since starting a previous steroid burst last year. The technician knows steroids can raise blood glucose and that insulin changes should be guided by a clinician. The patient's last A1c recorded in the profile is elevated, and the patient has had a prior emergency visit for high blood sugar. Pharmacy policy requires pharmacist review when patients request advice about adjusting prescription doses or report symptoms that could indicate uncontrolled glucose. The technician must decide the best course of action to protect the patient and stay within scope.
Answer: Refer the patient to the pharmacist for counseling on steroid effects and insulin management
This question tests the ability to identify situations requiring pharmacist intervention, focusing on patient safety and quality assurance in pharmacy settings. Pharmacist intervention is crucial when potential drug interactions, therapeutic duplications, or ADEs are identified, ensuring patient safety and optimal therapeutic outcomes. In the specific scenario, the prednisone prescription in a diabetic patient on insulin highlights the need for a pharmacist's expertise to prevent harm. The correct answer addresses the specific situation requiring pharmacist oversight for glucose effects and dose adjustments, demonstrating comprehension of the intervention criteria. A common distractor might allow patient self-adjustment of insulin, reflecting a misunderstanding of pharmacy protocols. To help students, emphasize the importance of understanding common triggers for pharmacist review and practice identifying these in varied scenarios. Encourage familiarity with drug interaction resources and therapeutic guidelines.
- A patient picking up medications tells the technician, "Ever since I started my new water pill, I feel my heart racing and my muscles cramp." The technician checks the profile: furosemide 40 mg daily was started three days ago, along with existing digoxin 0.125 mg daily for heart failure and metoprolol succinate 50 mg daily. The patient also takes a potassium supplement intermittently but is not sure how often. The patient denies chest pain but feels dizzy when standing. The technician knows that some diuretics can lower potassium, and that low potassium can increase the risk of side effects with certain heart medications. The patient asks whether they should take extra potassium tablets today. The pharmacy's policy requires pharmacist involvement when a patient reports possible medication side effects, dizziness, or symptoms that could indicate electrolyte problems. The technician must decide how to proceed to ensure patient safety and appropriate clinical assessment.
Answer: Refer the patient to the pharmacist for evaluation of possible adverse effects and interaction risk
This question tests the ability to identify situations requiring pharmacist intervention, focusing on patient safety and quality assurance in pharmacy settings. Pharmacist intervention is crucial when potential drug interactions, therapeutic duplications, or ADEs are identified, ensuring patient safety and optimal therapeutic outcomes. In the specific scenario, the symptoms of heart racing and cramps after starting furosemide with digoxin highlight the need for a pharmacist's expertise to prevent harm. The correct answer addresses the specific situation requiring pharmacist oversight for electrolyte issues and interactions, demonstrating comprehension of the intervention criteria. A common distractor might suggest self-adjustment of supplements, reflecting a misunderstanding of pharmacy protocols. To help students, emphasize the importance of understanding common triggers for pharmacist review and practice identifying these in varied scenarios. Encourage familiarity with drug interaction resources and therapeutic guidelines.
- A patient requests an OTC antacid for heartburn and tells the technician they are taking mycophenolate for a transplant, along with tacrolimus and prednisone. The patient says they have been nauseated and want something "fast-acting," pointing to magnesium/aluminum hydroxide liquid. The patient also mentions they have had diarrhea recently and are worried about dehydration. The technician knows some antacids can affect absorption of certain prescription medications and that transplant medicines require consistent levels. The patient asks if they can take the antacid at the same time as their morning transplant medications to keep their routine simple. Pharmacy policy requires pharmacist consultation when OTC products may reduce effectiveness of critical therapies or when the patient reports ongoing gastrointestinal symptoms. The technician must decide how to proceed to support patient safety and therapy success.
Answer: Refer to the pharmacist due to potential absorption issues with transplant medications and symptoms
This question tests the ability to identify situations requiring pharmacist intervention, focusing on patient safety and quality assurance in pharmacy settings. Pharmacist intervention is crucial when potential drug interactions, therapeutic duplications, or ADEs are identified, ensuring patient safety and optimal therapeutic outcomes. In the specific scenario, the OTC antacid request with transplant medications and symptoms highlights the need for a pharmacist's expertise to prevent harm. The correct answer addresses the specific situation requiring pharmacist oversight for absorption interactions, demonstrating comprehension of the intervention criteria. A common distractor might allow simultaneous timing without review, reflecting a misunderstanding of pharmacy protocols. To help students, emphasize the importance of understanding common triggers for pharmacist review and practice identifying these in varied scenarios. Encourage familiarity with drug interaction resources and therapeutic guidelines.
- A patient comes to the counter and says they started allopurinol last week for gout prevention. They now have a new rash on their chest and arms and feel feverish. The technician reviews the profile: allopurinol 300 mg daily is new, and the patient also takes hydrochlorothiazide and lisinopril. The patient asks if they should apply an OTC hydrocortisone cream and keep taking allopurinol because "it's probably just dry skin." The technician knows that new rash with fever after starting a medication can be a warning sign and may require urgent evaluation. The patient's history includes kidney problems, and the patient looks uncomfortable. Pharmacy policy requires immediate pharmacist involvement when a patient reports possible serious adverse drug reactions, especially after starting a new medication. The technician must decide the best course of action to ensure prompt and appropriate care.
Answer: Refer the patient to the pharmacist immediately due to possible serious drug reaction signs
This question tests the ability to identify situations requiring pharmacist intervention, focusing on patient safety and quality assurance in pharmacy settings. Pharmacist intervention is crucial when potential drug interactions, therapeutic duplications, or ADEs are identified, ensuring patient safety and optimal therapeutic outcomes. In the specific scenario, the new rash and fever after starting allopurinol highlight the need for a pharmacist's expertise to prevent harm. The correct answer addresses the specific situation requiring pharmacist oversight for serious drug reactions, demonstrating comprehension of the intervention criteria. A common distractor might treat symptoms with OTC without urgent review, reflecting a misunderstanding of pharmacy protocols. To help students, emphasize the importance of understanding common triggers for pharmacist review and practice identifying these in varied scenarios. Encourage familiarity with drug interaction resources and therapeutic guidelines.
- A prescriber writes for clopidogrel 75 mg daily for a patient after a recent stent placement. While processing the prescription, the technician sees the patient's active medications include omeprazole 20 mg daily for reflux, atorvastatin, and lisinopril. The patient asks if they can continue taking their "stomach pill" because heart medications upset their stomach. The technician recalls that some acid-reducing medications can reduce the effect of clopidogrel, and the patient's recent cardiac procedure makes medication effectiveness especially important. The patient's history includes a prior gastrointestinal bleed years ago, which is why omeprazole was started. The technician is unsure how to balance bleeding risk and heart protection and knows this requires pharmacist judgment. Pharmacy policy requires pharmacist review for potential interactions that may reduce therapy effectiveness, especially after hospital discharge. The technician must determine what issue necessitates pharmacist oversight before finalizing the fill.
Answer: Refer to the pharmacist due to a possible interaction affecting clopidogrel effectiveness
This question tests the ability to identify situations requiring pharmacist intervention, focusing on patient safety and quality assurance in pharmacy settings. Pharmacist intervention is crucial when potential drug interactions, therapeutic duplications, or ADEs are identified, ensuring patient safety and optimal therapeutic outcomes. In the specific scenario, the potential interaction between clopidogrel and omeprazole highlights the need for a pharmacist's expertise to prevent harm. The correct answer addresses the specific situation requiring pharmacist oversight for reduced effectiveness risks, demonstrating comprehension of the intervention criteria. A common distractor might ignore the interaction without review, reflecting a misunderstanding of pharmacy protocols. To help students, emphasize the importance of understanding common triggers for pharmacist review and practice identifying these in varied scenarios. Encourage familiarity with drug interaction resources and therapeutic guidelines.
- During the final check of a prescription, a pharmacist is talking to a patient. The conversation reveals the patient thought their prescription for amlodipine 5 mg was supposed to be for amiloride 5 mg. This discovery prevents what type of medication error?
Answer: Incorrect drug
Amlodipine and amiloride are look-alike/sound-alike (LASA) medications with very different purposes. The pharmacist's intervention by counseling the patient caught an error where the patient was about to receive the wrong medication. This is a classic 'incorrect drug' error that was prevented by quality assurance measures like patient counseling.
